Skip to main content
. 2020 Sep 30;13(11):1664–1670. doi: 10.1016/j.jiph.2020.09.009

Table 2.

Drug Usage for COVID-19 Treatment.

n /%
HQ (-) 393 17.7%
(+) 1824 82.3%
Azithromycine (-) 1230 55.5%
(+) 987 45.5%
Oseltamivir (-) 1460 65.9%
(+) 757 34.1%
Lop/Rit (-) 2145 96.8%
(+) 72 3.2%
Favipravir (-) 2157 97.2%
(+) 60 2.7%
Antibiotherapy (-) 1893 85.4%
(+) 324 14.6%

HQ: Hydroxychloroquine, Lop/Rit: Lopinavir/Ritonavir.